Erelzi — Medical Mutual

Initial criteria

• Patient age > 18 years
• Medication prescribed by or in consultation with a rheumatologist

Reauthorization criteria

• Patient has been established on etanercept therapy for at least 6 months
• Patient experienced a beneficial clinical response with objective measures OR experienced improvement in at least one symptom (e.g., decreased pain, stiffness, improved function)

Approval duration

initial 6 months, reauth 1 year